Table 1.
Demographics of 330 gastrointestinal neuroendocrine carcinoma with bone metastasis at diagnosis.
| Variable | Value |
|---|---|
| Race | |
| White | 261 (79.1%) |
| Black | 43 (13.0%) |
| Others | 26 (7.9%) |
| Gender | |
| Female | 123 (37.3%) |
| Male | 207 (62.7%) |
| Age (years) | |
| ≤60 | 125 (37.9%) |
| >60 | 205 (62.1%) |
| Tumor location | |
| Colon and rectum | 83 (25.2%) |
| Pancreas, liver, stomach | 164 (49.7%) |
| Others | 83 (25.2%) |
| Tumor size (cm) | |
| <5 | 110 (33.3%) |
| ≥5 | 85 (25.8%) |
| Unknown | 135 (40.9%) |
| Surgery | |
| Yes | 34 (10.3%) |
| No | 296 (89.7%) |
| Radiotherapy | |
| Yes | 108 (32.7%) |
| No | 222 (67.3%) |
| Chemotherapy | |
| Yes | 180 (54.5%) |
| No | 150 (45.5%) |
| Brain metastasis | |
| No | 294 (89.1%) |
| Yes | 21 (6.4%) |
| Unknown | 15 (4.5%) |
| Liver metastasis | |
| No | 73 (22.1%) |
| Yes | 251 (76.1%) |
| Unknown | 6 (1.8%) |
| Lung metastasis | |
| No | 234 (70.9%) |
| Yes | 78 (23.6%) |
| Unknown | 18 (5.5%) |
| Marital status | |
| Married | 183 (55.5%) |
| Others | 131 (39.7%) |
| Unknown | 16 (4.8%) |
| Dead | |
| Yes | 257 (77.9%) |
| No | 73 (22.1%) |
| 1-year OS rate | 39.50% |
| 1-year CSS rate | 40.00% |
| 3-year OS rate | 16.70% |
| 3-year CSS rate | 17.00% |
OS, overall survival; CSS, cancer-specific survival.